ArticleVaccines2023

Real-World Efficacy of COVID-19 Pre-Exposure Prophylaxis with Tixagevimab/Cilgavimab in People with Multiple Sclerosis.

Luke B Elias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.